Table 2.
Compound | Structure | Mechanism of Action | References |
---|---|---|---|
β-pinene | Decreased expression of IL-6, TNF-α, NO, iNOS and COX-2. Down-regulation of MAPKs phosphorylation and the NF-κB signaling pathway |
[127] | |
Inhibition of COX-2 enzyme expression | [128] | ||
Limonene | Reduction in leukocyte infiltration and TNF-α levels. | [129] | |
Decreased production of NO, PGE2 and Pro-inflammatory cytokines | [130] | ||
Linalool | Inhibition of pro-inflammatory interleukins and modulation of NMDA glutamatergic receptor. | [131] | |
Reduction in oxidative stress and inflammation (NF-kB). | [132] | ||
Activation of opioid and muscarinic receptors | [133] | ||
Myrcene | Activation of opioid receptors and presynaptic α2 adrenoreceptor. | [134] | |
Inhibition of IL-1β-induced NO production Increased expression of TIMP-1 and TIMP-3. |
[135] | ||
p-cymene | Reduced the production of pro-inflammatory cytokine TNF-α, the migration of leukocytes, and the release of NO. Activation of opioid receptors. | [136] | |
Reduced the calcium current density. | [137] | ||
Thymol | Voltage-operated sodium channel blocker | [138] | |
TRPA1 channel presynaptic activation | [139] | ||
Carvacrol | Inhibition of expression TNF-α, IL-1β, and IL-6 Reduced the expression of NF-kB |
[140] | |
Modulation of opioid, vanilloid and glutamate systems | [141] | ||
α-humulene | Inhibition of pro-inflammatory cytokines (TNF-α and IL-1β) and PGE2 generation. Decreased expression of iNOS and COX-2. Inhibition of Il-5, CCL11 and LTB4 levels and P-selectin expression. |
[142] [143] |
|
β-caryophyllene | Cannabinoid receptor type 2 agonist. Attenuation of Substance P and cytokines such as IL-1β, TNF-α, and IL-6. |
[144] | |
Agonist to opioid, benzodiazepine, 5HT1A receptors and NO. | [145] |
Abbreviations: COX-2: Cyclooxygenase-2; IL-: Interleukin-; iNOS: Inducible nitric oxide synthase; LTB4: Leukotriene B4; MAPKs: Mitogen-activated protein kinase; NF-kB: Nuclear factor kappa-light-chain-enhancer of activated B cells; NMDA: N-methyl-D-aspartate receptor; NO: Nitric oxide; PGE2: Prostaglandin E2; TIMP-: Tissue inhibitors of metalloproteinase-; TNF-α: Tumor necrosis factor-alpha; TRPA1: Transient receptor potential cation channel, subfamily A, member 1.